MDMA-Assisted Therapy

Though MAPS’ long series of interactions with multiple IRBs was often frustrating, several improvements have been incorporated into the protocol design as a result of recommendations/requirements …

MAPS sends a letter to all members of the National Institute on Drug Abuse’s National Advisory Council on Drug Abuse, requesting that it recommend that NIDA release all the information about Dr. …

Nature publishes a short news story (PDF and HTML) on the MAPS sponsored MDMA/PTSD study. Nature 425, 552 (09 October 2003) MAPS has a few comments on the article.

MAPS receives a confirmation letter from NIDA’s Freedom of Information Act (FOIA) staff that it has received our request for specific information about the studies that Drs. Ricaurte et al. conducted …

The Institutional Review Board (IRB) reviewing Dr. Mithoefer’s MDMA/PTSD protocol made its final decision — and approved the study! This is a historic moment for MAPS and for MDMA research. …

MAPS sends a letter to NIDA Director Nora Volkow noting the many unanswered questions in the Ricaurte et al. retraction and requesting the release of additional information. MAPS states that the credibility …

For the last several months, another independent Institutional Review Board (IRB) has been reviewing Dr. Michael Mithoefer’s MAPS -sponsored MDMA/PTSD protocol. Today, we submitted our response to …

Drs. Mithoefer, Jerome and Doblin have written a reply to the Ricaurte et al. letter published in Science on June 6, 2003. We have submitted our reply to Drs. Ricaurte and McCann and indicated that we …

The new IRB informed MAPS today that it has decided not to accept the protocol for review. MAPS was clearly told in writing a month ago that this IRB would accept the protocol for review. Now, after we …